# Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

> **NCT03103685** · PHASE4 · UNKNOWN · sponsor: **Chiang Mai University** · enrollment: 428 (estimated)

## Conditions studied

- Dental Diseases
- Antiplatelet Agents
- Antiplatelet Drugs

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03103685
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2017-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03103685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03103685, "Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03103685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*